Clinical Trials Logo

Prevention clinical trials

View clinical trials related to Prevention.

Filter by:

NCT ID: NCT03192514 Terminated - Prevention Clinical Trials

Electronic Deprescribing Tool for the Prevention of PIP

Start date: October 2, 2017
Phase: N/A
Study type: Interventional

This study is a cluster randomized control trial aimed to measure the effectiveness of an educational knowledge transfer intervention to prescribers on the discontinuation of two targeted classes: Benzodiazepines andNon-benzodiazepine hypnotics.

NCT ID: NCT03121079 Withdrawn - Prevention Clinical Trials

Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Allogeneic stem cell transplantation (SCT) remains a powerful therapeutic modality for patients with acute myeloid leukemia (AML).The superior clinical outcomes of allogeneic human SCT versus chemotherapy alone as post-remission treatment could be related to the graft-versus-leukemia (GVL) effects of recovered donor T cells. Our previous study investigated both the association of MRD status with transplant outcomes in haplo-SCT and matched sibling donor transplantation(MSDT), and also possible differences in the transplant outcomes of patients with positive pre-MRD (as determined by MFC) who underwent haplo-SCT versus MSDT. It provided new evidence that unmanipulated haplo-SCT is superior to matched sibling donor transplantation in eradicating pre-transplantation MRD, indicating that unmanipulated haploidentical allografts have stronger GVL effects.As to the AML patients in standard-risk, who have a positive MRD before MSDT, whether these patients should be given any relapse prevention is the question to be answered in this study. Interferon α-2b exerts a relatively strong immunomodulatory effect. It can kill AL cells by regulating T-cell and/or natural killer cell functions.Consequently, interferon α-2b may have potential value for high-risk AL patients after transplantation. The study hypothesis: Using interferon α-2b following hematopoietic stem cell transplantation in patients with standard-risk AML can further reduce relapse rate and improve leukemia-free survival.

NCT ID: NCT03086057 Completed - Prevention Clinical Trials

Optimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization Design

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

"PrEPare for Work" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Male Sex Workers (MSW).

NCT ID: NCT03084822 Completed - Obesity Clinical Trials

Cardiovascular Health Promotion Among African-Americans by FAITH!

FAITH!
Start date: March 2016
Phase: N/A
Study type: Interventional

Given the importance of healthy lifestyle practices to cardiovascular disease (CVD) prevention and the utility of church-based interventions in African-American adults, the investigators developed a theory-informed, strategically-planned, health and wellness intervention with Rochester, Minnesota (MN) and Twin Cities area (Minneapolis, St. Paul, MN) churches with predominately African-American congregations. The objective of the study was to partner with churches to implement a multi-component, health education program through the use of core educational sessions delivered through a digital-application accessible on demand via interactive access on computer tablets and the Internet. The overarching goal was to increase the awareness and critical importance of healthy lifestyles for CVD prevention and provide support for behavior change.

NCT ID: NCT03072030 Completed - Prevention Clinical Trials

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Start date: August 3, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate immunogenicity, epidemiological efficacy and safety of medicinal product GamEvac-Combi - Combined Vector-Based Vaccine against Ebola Virus Disease, 0.5 ml+0.5 ml/dose

NCT ID: NCT02981615 Completed - Prevention Clinical Trials

Phase 3 Multicenter Randomized Double Blind Placebo Controlled Study With Antibacterial Prophylaxis in Azacitidine Treated MDS Patients

Start date: August 1, 2017
Phase: Phase 3
Study type: Interventional

Infections are a major and prevalent life-threatening complication among patients with myelodysplastic syndrome (MDS). Currently, the role of prophylactic antibacterial agents after chemotherapy in MDS patients remains controversial and there are no clinical guidelines for infection prophylaxis in this clinical setting. We will conduct a prospective study to evaluate the potential benefit of prophylactic antibacterial (Levofloxacin) on the rate of febrile episodes/infections in Azacytidine treated MDS patients.

NCT ID: NCT02697409 Active, not recruiting - Prevention Clinical Trials

Education Against Tobacco Randomized Trial

Start date: March 2016
Phase: N/A
Study type: Interventional

A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7th grade of secondary school. The primary endpoint is the change in smoking prevalence between the two groups.

NCT ID: NCT02351570 Completed - Prevention Clinical Trials

Health Prevention Programmes to Patients Through Their General Practitioners

Start date: November 2010
Phase: N/A
Study type: Observational

By the health reform GKV in 2000 as well as by the competitive strengthening law GKV in 2007 in §20 SGB V the health insurance schemes have received an enlarged action frame in the primary prevention and the operational health support. Through these paragraphs arises the possibility for citizens to let refund health-supporting programmes or health training of the health insurance schemes. Doctor's recommendation is one of the most important predictors by therapy decisions of patients. At the same time, primary prevention takes a very small part of the working hours of general practitioners. Hence, is the aim of the present study to examine whether and how general practitioners could be incorporated in the mediation of prevention's offers. To reach this aim, must be grasped first, to what extent general practitioners are already integrated into in the mediation of the primary prevention courses. There is up to now no information about whether general practitioners know about the GKV-improved prevention programmes for GKV-insured person and whether they are involved in their mediation. This research project will close this gap. The aims of the study are: 1. to explore the roll of primary prevention in the general practitioner's consultation 2. to analyse which social institutions are responsible for primary prevention according to the general practitioner's opinion 3. to explore which primary prevention's programmes do general practitioners in their consultation recommend 4. to analyse which factors play a role in the mediation 5. to explore whether general practitioners with §20 are familiar. This is a mixed methods study which combines a mail survey of all general practitioners in Berlin with focus groups of 25 general practitioners. In this study all general practitioners of Berlin (n=1300) will be mailed. Participants for the focus groups are invited from the pool of teaching doctors of the Institute for General Medicine at the Charite. After both methods are analyzed on their own, the triangulation of the interpretation of both data sets will be done to find possible answers of the study questions. Bi-directionality of results will contribute to find possible interpretations of the survey responses in the results of the focus group discussions, as well as the results of the focus groups discussions could be explained by the results of the survey (Flick).

NCT ID: NCT02247258 Terminated - Crohn Disease Clinical Trials

Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.

Start date: October 2005
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate if in the prevention of postoperative recurrence of ileal Crohn's disease immediate initiation of azathioprine postoperatively is superior to delayed (6- 12 mths.) introduction of azathioprine upon disease recurrence assessed by endoscopic criteria. The primary endpoint, disease recurrence, encompasses symptomatic and surgical recurrence as well as severe endoscopic lesions at the final, 2 year, assessment.

NCT ID: NCT01924247 Completed - Stroke Clinical Trials

Study to Validate the Effects of an Outpatient Secondary Prevention Program for Stroke Victims

Start date: November 2013
Phase: N/A
Study type: Interventional

Background: Stroke represents one of the major health problems worldwide, particularly in transitional and industrialized countries. Stroke has a remarkable socioeconomic impact, especially in the ageing population, and therefore stroke prevention is important. Secondary preventive measures and rehabilitation are essential for reduction of recurrent events. However, to date appropriate secondary preventive programs for patients surviving a stroke with minor or no residual deficits have been poorly studied. Specific aims/projects: The aim of this study is to validate the effects of an outpatient secondary prevention program on vascular risk factors, adherence to vascular-protective medication, exercise capacity and health related quality of life. Working Hypothesis: The outpatient rehabilitation program results in a significant short (3 months) and long-term (1 year) improvement of vascular risk factors, neurological functions, exercise capacity, adherence to vasoprotective medication and health related quality of life. Experimental design/Methods: This is a prospective, randomized clinical trial. At least 100 patients will be randomized either to the interventional group or to a group which is treated only by the family physician. All patients will be assessed at baseline, at 3 months and 1 year. The primary outcome is the number of reached cardiovascular health goals (6 metrics) between the interventional group and the group which is treated only by the family physician. Expected value of the proposed project: The study has the potential to show that an outpatient rehabilitation program significantly improves vascular risk factors, adherence to medication, enhances quality of life and eventually reduces recurrent strokes and other vascular events. If this is confirmed, introducing outpatient rehabilitation programs will have a major socioeconomic impact.